Update on the Management of Spondyloarthritis in Asian Countries
Current Rheumatology Reviews, 07/09/2012
Huang Z et al. – Thalidomide has been shown to be an effective and safe drug in the treatment of SpA patients. Traditional Chinese Medicine (TCM) is a promising clinical therapy in the treatment of SpA. With these advances, the management of SpA has considerably progressed. But defining better strategies and techniques for early diagnosis and developing new treatment to prevent or delay the process of new bone formation remain the major challenges facing the rheumatologists in Asian countries.Methods
- Studies conducted in Asian countries in the past 3 years were included.
- Low quality evidences, which had too small sample size or lacked controlled group, were excluded.
- Through the analysis of the included literature, it was concluded that management of SpA in Asia has changed in recent years.
- More frequent uses of magnetic resonance imaging (MRI) in diagnosing SpA and successful uses of tumor necrosis factor (TNF) blockers in active, refractory diseases have significantly improved the management of SpA in Asia.
- In addition, there are some characteristic clinical therapies in Asian countries.